Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
61 /100
HIGH RISK
Score updated Aug 28, 2026

IMA — ImageneBio, Inc. Dilution Risk Tracker

Track IMA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IMA — Get alerts when the score changes →

As of August 28, 2026, ImageneBio, Inc. (IMA) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. ImageneBio, Inc. has a market capitalization of $66.32M, 11.35M shares outstanding, 38 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $30.00M, 5.77M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
60
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 37%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 51% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 18%
• Active ATM program with $30M remaining capacity
📉 Score Deterioration model 10%
• Score in HIGH risk zone (61/100)
🔔 Track IMA — Get forecast alerts →

Market Data

Market Cap$66.32M
Shares Outstanding11.35M
Float5.80M
Cash$136.15M
Debt$2.42M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 3.9% shares (2026Q1 vs prior)
38 institutional holders · 5.78M shares
#1 BVF INC/IL 1.11M shares
#2 Blue Owl Capital Holdings LP 959.3K shares
#3 Cable Car Capital, LP 754.7K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest384.5K
Days to Cover29.6
% of Float6.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
3 FORM3 2026-04-16
424B3 ATM 2026-04-13
Full SEC filing analysis available with free account

Recent News

No recent news

Factual IMA Dilution Snapshot

ImageneBio, Inc. (IMA) has a DilutionScore of 61/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track IMA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IMA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IMA
IMA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.